Treatment approaches include endocrine therapies, targeted therapies, and different types of chemotherapy, which are based upon the identification of breast cancer subtype (BCS) based on the hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status [9]. The gene discussed is ERBB2; the disease is breast carcinoma.